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Abstract Parkinson’s disease (PD) is the most frequent
neurodegenerative movement disorder and manifests at old
age. While many details of its pathogenesis remain to be
elucidated, in particular the protein and mitochondrial
quality control during stress responses have been implicated
in monogenic PD variants. Especially the mitochondrial
kinase PINK1 and the ubiquitin ligase PARKIN are known
to cooperate in autophagy after mitochondrial damage. As
autophagy is also induced by loss of trophic signaling and
PINK1 gene expression is modulated after deprivation of
cytokines, we analyzed to what extent trophic signals and
starvation stress regulate PINK1 and PARKIN expression.
Time course experiments with serum deprivation and
nutrient starvation of human SH-SY5Y neuroblastoma cells
and primary mouse neurons demonstrated phasic induction
of PINK1 transcript up to twofold and PARKIN transcript
levels up to sixfold. The corresponding threefold starvation
induction of PARKIN protein was limited by its transloca-
tion to lysosomes. Analysis of primary mouse cells from
PINK1-knockout mice indicated that PARKIN induction
and lysosomal translocation occurred independent of
PINK1. Suppression of the PI3K-Akt-mTOR signaling by
pharmacological agents modulated PARKIN expression
accordingly. In conclusion, this expression survey demon-
strates that PARKIN and PINK1 are coregulated during
starvation and suggest a role of both PD genes in response
to trophic signals and starvation stress.
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Introduction
Parkinson’s disease (PD) is after Alzheimer’s disease the
second most frequent neurodegenerative disease, with both
syndromes being probably triggered by a combination of
genetic predisposition and cumulative effects of environ-
mental and physiological stressors, manifesting progres-
sively with old age [1]. The resulting clinical movement
deficit in PD is largely explained by the selective atrophy of
dopaminergic neurons in the midbrain. The accumulation of
ubiquitinated cytoplasmic aggregates (“Lewy bodies”)
containing proteins such as α-synuclein and the appearance
of oxidative stress in the affected tissues are established
hallmarks of PD pathology. Rodents treated with the
neurotoxins 6-OH-dopamine or the mitochondrial inhibitor
1-methyl-4-phenylpyridinium (MPP
+) exhibit characteristic
disease symptoms and were crucial to establish therapies.
Over the past decade, the identification of more than a
dozen mutant genes responsible for monogenic PD syn-
dromes [2, 3] and another dozen PD candidate genes with
significant risk association in GWAS studies [4–6] has
greatly advanced our knowledge about pathogenesis, but
the function of most corresponding gene products is still
enigmatic and the pathways in common for both autosomal
dominant and recessive PD variants remain elusive.
The PARKIN gene encoded at the PARK2 locus was
identified particularly early as a frequent cause of young-
onset autosomal recessive PD, and its protein sequence
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DOI 10.1007/s10048-011-0303-8clearly codes for an ubiquitin E3 ligase [7]. Initial
assumptions about its role for polyubiquitination and
proteasomal protein degradation [8] are now being chal-
lenged, and its relevant substrates and its relevant loss of
function are being discussed controversially, e.g., regarding
mitochondrial DNA damage, autophagy, and apoptosis [9–
13]. One isolated report with particularly convincing data
demonstrated a role of PARKIN for receptor tyrosine kinase
(RTK) endocytosis and signaling, implicating it in growth
regulation [14]. PARKIN expression can be upregulated in
dependence on ATF4, a transcription factor triggered by
mitochondrial stress and the unfolded protein response [15].
Some PARKIN functions were shown to be downstream
of Pten-induced protein kinase 1 (PINK1), a mitochondrial
outer membrane kinase encoded at the autosomal recessive
PARK6 locus [16, 17]. PINK1 provides protection against
ROS-induced damage, and its mRNA level increases with
progressive cell age [18]. Furthermore, PINK1 is transcrip-
tionally induced in response to stress via FOXO3a and is
stabilized against proteolytic degradation when the mito-
chondrial membrane potential dissipates [19, 20]. In
Drosophila melanogaster the loss of PINK1 and PARKIN
results in increased mitochondrial fission [21–23]. The role
of PINK1 in mitochondrial dynamics of mammalian cells,
however, is more complex and controversial as reviewed
recently [24]: PINK1 was described to act as a fission factor
[23] as well as a fusion factor [25, 26], while our PINK1-
knockout mouse model demonstrated no effect on the
mitochondrial morphology of unstressed cells [27]. PINK1
and PARKIN appear to act together also in the degradation
of damaged mitochondria (mitophagy) [28–31]. It was
proposed that the accumulation of PINK1 protein in
dysfunctional mitochondria is a prerequisite for the reloc-
alization of PARKIN from the cytosol to the mitochondrial
outer membrane [19, 28, 29]. There is ongoing debate
whether this is caused via direct phosphorylation and which
other proteins interact with PINK1 and PARKIN [29, 32,
33]. It is also unclear which environmental and physiolog-
ical stress events play the prominent role for the PINK1/
PARKIN pathway. The relevance of stress was particularly
investigated for the polyubiquitin–proteasome degradation
of proteins [17, 27, 34, 35], but recently, the mutation
effects could be maximized when potent mitochondrial
uncouplers like CCCP were used as stressor [36].
In view of the regulation of PINK1 in response to a more
physiological challenge namely cytokine deprivation [20],
we were interested whether the physiological competition
for nutrients and growth factors which control autophagy
[37] has a role in the regulation of PARKIN. A previous
study reported PARKIN expression to be downregulated in
SH-SY5Y neuroblastoma cells by proteasomal stress, but
unchanged after oxidative stress and ER stress, while an
independent study observed PARKIN upregulation in some
neuroblastoma cell lines after ER stress [38, 39]. Our
observations indicate that trophic deprivation and nutrient
starvation cause distinct regulations of PARKIN and PINK1
in neuronal cells.
Material and methods
Chemicals and media
Bafilomycin A1, rapamycin (all Sigma-Aldrich, Taufkirchen,
Germany) and LY294002 (Jena Bioscience, Jena, Germany)
stocks were prepared with DMSO and stored at −20°C until
use. All cell culture media, L-glutamine, penicillin G–
streptomycin solution, and minimal essential medium with
Earle’s salts (MEM) nonessential amino acids were pur-
chased from Invitrogen (Karlsruhe, Germany), DMSO and
PBS were from Sigma-Aldrich (Taufkirchen, Germany).
Cell culture
SH-SY5Y cells were purchased from The European
Collection of Cell Cultures (Sigma-Aldrich, Taufkirchen,
Germany) and cultured in Roswell Park Memorial Institute
(RPMI) 1,640 medium containing 2 g/l D-glucose, 2 mM L-
glutamine and 10% FCS. HeLa cells were obtained from
Deutsche Sammlung von Mikroorganismen und Zellkultu-
ren GmbH (Braunschweig, Germany, DSM-No. ACC57)
and were cultured in MEM supplemented with 10% FCS
and 1% MEM nonessential amino acids. Primary cortical
neurons were isolated from 1- to 4-day-old mice as
described before [27] and were kept in Neurobasal medium
with 10 mM L-glutamine for 10–20 days before performing
experiments. Mouse embryonic fibroblasts (MEF) were
isolated from mouse embryos with standard procedures and
cultivated in DMEM with 4.5 g/l D-glucose supplemented
with 15% BGS (Fisher Scientific, Schwerte, Germany). All
cells were kept at 37°C with 5% CO2 and 95% air.
Starvation experiments
SH-SY5Y cells were starved of trophic factors by incubating
them in their normal growth medium (RPMI 1640 containing
2g / lD-glucose and 2 mM L-glutamine) but without FCS
(serum starvation). The starvation effect was maximized by
incubating SH-SY5Y cells and primary neurons in HBSS
(Invitrogen, nutrient starvation). HBSS contains 1.26 mM
CaCl2, 0.493 mM MgCl2 ×6 H 2O, 0.407 mM MgSO4 ×
7H2O, 5.33 KCl, 0.441 KH2PO4, 4.17 mM NaHCO3,
137.93 mM NaCl, 0.338 mM Na2HPO4, 0.0266 mM Phenol
Red, and 5.56 mM (1 g/l) D-glucose but no amino acids.
To analyze mRNA levels by real-time reverse transcrip-
tase quantitative PCR (qPCR), 0.5×10
6 SH-SY5Y cells
10 Neurogenetics (2012) 13:9–21were seeded in a six well, while 2.5×10
6 SH-SY5Y cells
were seeded in a 10-cm dish to investigate protein
expression, always 20 h prior to experimental start.
Medium was removed, cells washed with PBS and covered
with 2 ml (for RNA) or 10 ml (for protein) of control
medium or starvation medium as indicated in the figure
captions. Neurons were starved without washing them with
PBS. Afterwards cells were incubated for the appropriate
time at 37°C, 95%, air and 5% CO2. Neuron starvation
experiments were performed in two to four individual
neuron cultures for each genotype and time point.
RNA isolation, cDNA synthesis, and quantitative real-time
PCR
Supernatant medium was collected and spun down (5 min,
500×g, 4°C). Cell pellets were combined with adherent cells,
and both were washed twice with PBS. Lysis of cells and
isolation of total RNA was carried out utilizing the RNeasy
mini kit (QIAGEN, Hilden, Germany). For first-strand
synthesis, 1 μg of total RNA was digested with DNase I
and reverse transcribed with SuperScript III reverse tran-
scriptase utilizing oligo(dT)20 and random primers (all
Invitrogen, Karlsruhe, Germany). Transcript changes of
30 ng cDNA per sample were analyzed in a 20-μlr e a c t i o n
volume with qPCR in a StepOnePlus Real-Time PCR
System and the appropriate TaqMan gene expression assays
(all Applied Biosystems, Darmstadt, Germany): SGK1
(Hs00178612_m1), FOXO3a (Hs00921424_m1), PINK1
(Hs00260868_m1), and PARKIN (Hs01038318_m1). Mean
of expression changes was normalized to mean of TATA
box-binding protein (TBP: Hs99999910_m1) as an internal
“housekeeping” control. For analysis of mRNA levels from
mouse neurons, TaqMan gene expression assays pink1
(Mm00550827_m1), parkin (Mm00450186_m1), and tbp
(Mm00446973_m1) were used. Relative expression changes
were calculated with the 2
−ΔΔCt method [40] utilizing
Microsoft Excel 2007 software, whereupon the ΔCt of the
corresponding control served as calibrator. The resulting
2
−ΔΔCt values of n experiments (indicated in the figures) were
averaged for the appropriate time and treatment.
SDS-PAGE and western blotting
To determine PARKIN and LC3 protein expression, adherent
cells were collected by scraping in 5 ml PBS supplemented
with Complete EDTA free protease inhibitor (PI) cocktail
(Roche Diagnostics GmbH, Mannheim, Germany), centri-
fuged for 5 min at 500×g, 4°C and combined with floating
cells, which were likewise spun down. Cell pellets were
washed twice with PBS-PI (5 min, 4°C). The resulting cell
pellets were frozen in liquid nitrogen and stored at −80°C
until further analysis. Proteins were extracted with 2× SDS
lysis buffer (137 mM Tris/HCl pH 6.8, 4% SDS, 20%
glycerol) and freshly added PhosSTOP phosphatase inhibitor
and PI cocktail (all Roche Diagnostics GmbH, Mannheim,
Germany). Samples were sonicated (5 s, 3 cycles×10%, 40%
power) with a Sonopuls UW2070 ultrasonic homogenizer to
advance cell lysis, to destroy DNA and to homogenize the
samples. Afterwards samples were spun down (20 min,
16,100×g, RT). Subsequently protein concentration was
determined with the BC assay protein quantitation kit
(VWR, Darmstadt, Germany). To investigate PARKIN
expression, 30 μg protein per sample, prepared with 6×
Laemmli sample buffer, were boiled for 5 min at 95°C and
separated on a 10% SDS gel. Proteins were transferred to
nitrocellulose membrane (Whatman, Dassel, Germany) by
wet blotting (50 V, 90 min). Membranes were blocked for
1hw i t h5 %s k i mm i l kp o w d e r / T B S –Tween (0.05%) and
probed with primary monoclonal (clone PRK8) mouse anti-
PARKIN [41] antibody (New England Biolabs, Frankfurt,
Germany) at titer 1:1,000 overnight at 4°C. Specificity of
anti-PARKIN antibody was controlled utilizing PARKIN-
knockout (ko) and wild-type (wt) mouse brain samples.
Quantification of PARKIN and equal protein loading was
controlled by normalization to GAPDH (monoclonal (6C5)
antimouse, 1:15,000; Merck, Darmstadt, Germany). Primary
antibodies were detected with IRDye 800CW conjugated
goat antimouse IgG secondary antibody (1:20,000, 1 h, RT)
on the Odyssey Infrared Imaging System (both LI-COR, Bad
Homburg, Germany). Band intensities were measured with
the appropriate Odyssey software, and protein expression
ratios were calculated with Microsoft Excel 2007 software.
To investigate autophagosome formation 30 μg protein from
each sample were separated on a NuPage 12% Bis–Tris
precast gel utilizing 1× NuPage MOPS SDS running buffer
(both Invitrogen, Karlsruhe, Germany). LC3 protein was
detected through chemiluminescence on a PVDF membrane
(Bio-Rad Laboratories, Munich, Germany). Membranes
were probed with a monoclonal antimouse LC3 (clone
2G6) antibody (Nanotools, Tenningen, Germany) at titer
1:500. Primary antibody was detected with a secondary ECL
antimouse IgG HRP-linked antibody (Amersham Bioscien-
ces, Glattbrugg Switzerland) at titer 1:15,000 on ECL
hyperfilm (Amersham Biosciences). The ratio of LC3-II/
GAPDH expression was determined by quantification of the
western blot with ImageJ.
Constructs and transfection
GFP-PARKIN has been described previously [42]. To
obtain cherry-GFP-PARKIN an existing cherry-GFP fusion
protein was digested with BspEI and BamH1 to remove the
insert. Into these sites the PARKIN ORF was cloned after
digesting GFP-PARKIN with BspEI and BamH1. All
constructs were verified by sequencing. SH-SY5Y cells
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line transfection kit V respective with the MEF transfection
kit and the Nucleofector II (all Lonza, Basel, Switzerland)
according to the manufacturer’s instruction. HeLa cells
were transfected with Effectene (Qiagen, Hilden, Germany)
likewise according to the manufacturer’s instruction.
Confocal laser scanning microscopy and immunostaining
LAMP-1 and LAMP-2 were detected with anti-LAMP-1
CD 107A and anti-LAMP-2 CD 107B antibody, while p62/
SQSTM1 was detected with anti-p62 Ick ligand as primary
antibody (all BD Bioscience, Heidelberg, Germany). Cy2-
conjugated Affini Pure Donkey antimouse IgG (H+L)
antibody served as secondary antibody (Dianova, Hamburg,
Germany). All microscopic analyses were performed with a
Leica TCS SP5 confocal laser scanning microscope
equipped with the appropriate filters and a HCX PL APO
lambda blue 63.0×, 1.40 OIL UV objective that was
controlled by the LAS AF scan software (version 1.8.2)
(Leica Microsystem, Wetzlar, Germany). Pictures were
visualized with IMARIS 6.0.0 (BITPLANE Scientific
solutions), and no deconvolution was performed. Images
were maximum image projections apart from the insets in
Fig. 3c, d which represent single slices.
Statistics
Raw data generated with Microsoft Excel 2007 were
transferred to GraphPad Prism 4.03 software to calculate
mean, SEM, and P values. For qPCR significance was
calculated by unpaired t test between mean of 2
−ΔΔCt values
under different conditions, e.g., nonstarved (RPMI+FCS)
vs. starved (HBSS−FCS) for the corresponding time.
Experimental variation was whenever possible (qPCR)
calculated by averaging ΔΔCt values of the controls of n
experiments and generating 2
−ΔΔCt values. SEM is indicated
by error bar in the figures. One-way ANOVA followed by
Tukey posttest was used to calculate statistics for PARKIN
protein expression change (Fig. 2b) and mRNA changes of
primary neurons (Fig. 5). P values smaller than 0.05-fold
were considered to be significantly different: *P≤0.05,
**P≤0.01, and *** P≤0.001.
Results
Serum deprivation of SH-SY5Y neuroblastoma cells results
in decreased SGK1 and increased FOXO3a, PINK1,
and PARKIN transcript levels
In view of the role of PINK1 in the stress response pathway
of cytokine deprivation [20], we aimed to gain a deeper
understanding of PARKIN, which is putatively acting
downstream of PINK1 in the signaling network. As first
step we analyzed the PARKIN mRNA expression in
different cell systems used as PD models. HEK-293 cells
exhibited low PARKIN mRNA levels, while HeLa cells,
which were used as control, contained no PARKIN as
shown before [41, 43] (Fig. S1). In contrast, fibroblasts had
a very high PARKIN transcript expression and the expres-
sion levels of the human dopaminergic neuroblastoma cell
line SH-SY5Y lay between fibroblasts and HEK-293 cells.
Since PD affects preferentially the dopaminergic nigros-
triatal projection, we chose the SH-SY5Y cells as the best
characterized and established PD in vitro model system. We
subjected SH-SY5Y to serum deprivation by incubating
them in RPMI medium with 2 g/l D-glucose and 2 mM L-
glutamine but without FCS and compared them to cells
incubated in RPMI medium with 10% FCS. Cells were
subjected to a 72-h time course, and the transcript levels of
PARKIN, PINK1, and the transcription factor FOXO3a,
which is known to upregulate PINK1 expression as part of
an antiapoptotic response to cytokine withdrawal [20], were
analyzed. FOXO3a itself was observed to aggregate in
Lewy bodies and is thus implicated in the pathogenesis of
PD [44]. Serum/glucocorticoid-regulated kinase 1 (SGK1)
was used as a positive control in view of the known strong
dependence of its transcript levels from serum availability;
furthermore, SGK1 is known to inhibit FOXO3a function
via phosphorylation and it shows altered expression in the
MPP
+ mouse model of PD [45, 46].
In SH-SY5Y cultivated without FCS, reductions of
SGK1 appeared already at 2 h, became significant from 4
until 24 h, and were discernible until 72 h, with a peak of
five- to 10-fold downregulation at 12–24 h (Fig. 1). These
alterations were paralleled by the expected, approximately
1.5-fold significant induction of FOXO3a already at 2 h,
which lasted until 12–24 h, followed by a gradual decline to
the baseline by 72 h. They were also paralleled by a
delayed, approximately 1.5-fold significant induction of
PINK1 levels between 8 and 24 h, and a return to the
baseline at 48 h. The main finding of this experiment
presents the relatively early and high induction of PARKIN
levels, significant from 4 to 24 h, that reached threefold
values over starting levels at 12 h and returned to baseline
values by 48–72 h (Fig. 1), demonstrating that PARKIN
expression strongly depends on the presence of trophic
factors.
Additional nutrient starvation doubles the levels
of PARKIN and PINK1 mRNA induction in SH-SY5Y
cells
To investigate if the induction of PINK1 and PARKIN
mRNA is part of a graded response to trophic deprivation,
12 Neurogenetics (2012) 13:9–21the starvation stress was maximized by additional depriva-
tion from nutrients through a switch from RPMI medium
with 10% FCS to HBSS medium (1 g/l D-glucose, no serum
or amino acids, specific composition see “Material and
methods” section). Again mRNA levels of SGK1 were
maintained until 12 h under control conditions, but showed
significant reductions under starvation conditions with a
similar time course as in Fig. 1 and a peak again at 12 h, but
a stronger effect with more than 10-fold changes between
8 and 16 h (Fig. 2a). As with serum deprivation alone,
FOXO3a transcript levels were already significantly upre-
gulated at 2 h and reached an approximately 1.5-fold
induction by 4 h, but the upregulation was no longer
significant at 8 and 12 h suggesting that the additional
effects of nutrient starvation are mediated by further factors.
The induction of PINK1 mRNA levels was enhanced to
twofold values, with a peak and clear significance by 12
and 16 h as previously, but curiously a lack of significance
at 8 and 24 h in comparison to serum deprivation alone. In
contrast, the induction of PARKIN mRNA levels was
markedly enhanced until sixfold, again with a similar time
course of significant changes between 8 and 24 h and a
peak by 12–16 h, but no return to the baseline even after
72 h (Fig. 2a).
To assess whether this strong PARKIN mRNA induction
served to increase PARKIN protein levels or to maintain
PARKIN protein levels in compensation of autophagic
degradation, immunoblot analyses of PARKIN protein
levels were performed (Fig. 2b). Gradual increases of the
major 52-kDa and the minor 48-kDa PARKIN isoforms
until 72 h after starvation were observed without exhibiting
differences, peaking at an approximately threefold induc-
tion with high significance at 72 h. In conclusion, qPCR
and immunoblot data in neural cells confirm a graded
upregulation of PARKIN expression in response to serum
and nutrient withdrawal, suggesting a protective function of
PARKIN in periods of starvation.
Starvation-induced translocation of PARKIN to lysosomes
In view of the established role of PARKIN in mitophagy
[47], we hypothesized that the induction of PARKIN
expression during deprivation of trophic factors is related
to a putative function in the starvation-induced auto-
phagic degradation of proteins and/or organelles. To
investigate a possible role of PARKIN in the autophago-
lysosomal pathway, the fusion protein cherry-GFP-
PARKIN was constructed. As the green GFP fluores-
cence is sensitive towards acidity while the red cherry
fluorescence is stable under acid conditions, the pres-
ence of PARKIN in acid-containing lysosomes can be
monitored by the loss of its green fluorescence [48].
Microscopical analysis of transfected SH-SY5Y neuro-
blastoma cells exhibited green and red cytosolic fluores-
cence in a diffuse distribution throughout the cytosol at
t i m ep o i n t s2a n d4h[ F i g .3a (a–ba n dh –i)]. However,
s t a r t i n gf r o m8hw i t ham a x i m u ma r o u n d1 6ha n
increasing percentage of starved cells in HBSS medium
contained PARKIN punctae [Fig. 3a (j–n)] emitting only
red, but no green fluorescence. In contrast, control cells
kept in RPMI medium with 10% FCS showed similar
PARKIN punctae only much later (24–4 8h )a n di na
Fig. 1 Serum starvation of hu-
man SH-SY5Y dopaminergic
neuroblastoma cells cultured
without FCS elicits strong PAR-
KIN mRNA level changes. SH-
SY5Y dopaminergic neuroblas-
toma cells were cultured in
RPMI medium containing 10%
FCS (RPMI+FCS) or no serum
(RPMI−FCS). At the indicated
time points, the different tran-
scripts were quantified and nor-
malized for each stage of
starvation to nonstarvation
(RPMI+FCS) at time 2 h.
Strong PARKIN mRNA level
changes occurred as well as an
upregulation of PINK1 mRNA;
SGK1 and FOXO3a: n=3;
PINK1 and PARKIN: n=4
Neurogenetics (2012) 13:9–21 13lower amount per cell [Fig. 3a (f–g)]. At the end of the
observation period (48 h), the general amount of PARKIN
punctae in starved cells was reduced compared to the 16 h
peak and was similar under both conditions. These data
indicate that starvation triggered a phasic response of
PARKIN peaking at 16 h, with subcellular relocalization
and acid exposure, compatible with an association of
PARKIN with proteins or organelles that are degraded by
the autophago-lysosomal pathway.
To corroborate this notion, HeLa cells transfected with
cherry-GFP-Parkin were subjected to starvation medium
(HBSS−FCS). HeLa cells were chosen for this experiment
since these cells do not contain endogenous PARKIN [41, 43]
and are morphologically better for high-resolution microsco-
Fig. 2 The combination of
serum deprivation and nutrient
starvation potentiates the PAR-
KIN induction at the mRNA and
protein level in SH-SY5Y cells.
a Human SH-SY5Y dopaminer-
gic neuroblastoma cells were
cultured in RPMI medium con-
taining 10% FCS (RPMI+FCS)
or in HBSS without amino acids
and serum (HBSS−FCS) and
lowered glucose (1 g/l). At the
indicated time points the differ-
ent transcripts were quantified
and normalized to nonstarvation
(RPMI+FCS) at time 2 h; n=4.
b PARKIN protein expression
was analyzed by western blot
and normalized to GAPDH lev-
els. The specificity of anti-
PARKIN antibody was con-
trolled utilizing PARKIN-
knockout (ko) and wild-type
(wt) mouse brain samples.
PARKIN protein levels are sig-
nificantly increasing during
starvation after 36 h; n=3
14 Neurogenetics (2012) 13:9–21py than neuroblastoma cells. Already after 2 h starvation, the
HeLa cells exhibited red PARKIN punctae (Fig. 3b, upper
panel). Since bafilomycin A1 is known to block the
autophago-lysosomal flux, we sought additional evidence to
support the involvement of PARKIN in the autophagosomal
pathway. Indeed, incubation with bafilomycin A1 over 2 h
eliminated the exclusively red PARKIN punctae typical of
starved cells, with all detectable PARKIN punctae now
exhibiting both red and green fluorescence (Fig. 3b,l o w e r
panel). These observations confirm that bafilomycin A1
prevents the acidification of autophago-lysosomes [49]a n d
thus loss of the GFP signal, indicating it interferes with the
processing of PARKIN in the autophago-lysosomal pathway.
Furthermore, we analyzed whether PARKIN colocalized
with marker proteins of the lysosomal membrane and of the
protein degradation pathway. After transfection of HeLa cells
with cherry-PARKIN and starvation for 16 h, the lysosome-
associated membrane proteins LAMP-1 and LAMP-2 were
visualized by immunostaining. Some of the cherry-PARKIN
punctae colocalized completely with LAMP-1 (Fig. 3c)a n d
LAMP-2 (Fig. 3d), while other PARKIN punctae appeared to
be engulfed by lysosomes (see insets in Fig. 3c, d). After 16 h
starvation of transfected HeLa cells, also some p62/seques-
tosome 1 (SQSTM1) signals colocalized with PARKIN
punctae (Fig. 3e). SQSTM1 is associated with polyubiquiti-
nated protein aggregates to be degraded by autophagy.
To correlate the PARKIN translocation to lysosomes with
the time course of autophagy, an immunoblot analysis of the
autophagosome marker LC3 was performed (Fig. 3f), quanti-
fying the conversion of the cytosolic LC3-I (18 kDa) variant
to the autophagosome-bound LC3-II (16 kDa) by proteolytic
cleavage and lipidation. As a positive control, enrichment of
LC3-II was achieved by long-term treatment with bafilomycin
A1 (BAF), which blocks the fusion of autophagosomes with
lysosomes. LC3-II band intensity in starved SH-SY5Y cells
was maximal already after 2 h, diminished at later time points
and disappeared completely from 16 h onwards (Fig. 3f).
Thus the time course in starving neural cells indicates (1)
that autophagosome formation is initiated already at 2 h, (2)
that lysosomal engulfment of PARKIN starts around 8 h,
and (3) that autophagosome formation is already ceasing by
the time of maximal PARKIN mRNA induction at 16 h,
while (4) PARKIN protein continues to accumulate until
72 h. Overall, the data support the current views that
PARKIN associates with protein aggregates and/or organ-
elles on their way to autophagic degradation in lysosomes.
The starvation effect on PARKIN expression
can be mimicked by rapamycin or LY294002 and repressed
by bafilomycin A1 and LY294002
To further support the activation of PARKIN expression by
deprivation of trophic factors, we exposed control cells and
HBSS-starved cells to pharmacological agents which induce
autophagy (mTOR inhibitor rapamycin), block autophago-
some maturation (bafilomycin A1), or block the trophic factor
signaling via PI3K-Akt [PI3K inhibitor LY294002 (LY)],
quantifying the peak PARKIN mRNA induction at the 16 h
time point (Fig. 4a). In unstarved cells, bafilomycin A1
exerted no influence (Fig. 4a, BAF, white bar), while the
rapamycin and LY294002 were able to upregulate PARKIN
mRNA significantly up to twofold (RAP, LY, white bars).
Similar to previous observations, starvation triggered a
fourfold PARKIN mRNA induction compared to the PARKIN
mRNA levels at 16 h in unstarved cells (Fig. 4a, CON, black
bar). In starved cells (black bars), rapamycin treatment failed as
expected to enhance the starvation effect, while both bafilomy-
cin A1 and LY294002 limited the PARKIN induction from
fourfold to twofold, correlating with an impaired PARKIN
usage after bafilomycin A1 treatment (Fig. 3b). The repressing
effect of LY294002 here may be explained by its known
autophagy inhibition effects [50]. To validate these mRNA
data, the levels of endogenous PARKIN protein after 24 h
were determined by immunoblot analysis (Fig. 4b). In good
agreement with the transcript levels, PARKIN protein levels
w e r ev i s i b l ye n h a n c e di nu n s t a r v e dc e l l sb yr a p a m y c i no r
LY294002 and in starved cells treated only with DMSO.
Treatment of starved cells with bafilomycin A1 or LY294002
resulted in evident PARKIN reduction. Overall, the treatment of
starved and unstarved cells with pharmacological agents
supports our notion that PARKIN expression is indeed regulated
by trophic signaling via the PI3K-Akt-mTOR pathway.
Starvation-triggered PARKIN induction in primary neurons
and PARKIN relocalization in embryonal mouse fibroblasts
occur independent of PINK1 expression
As PARKIN and PINK1 are both induced by starvation and
PARKIN is known to rescue some PINK1 deficiency
phenotypes and is therefore thought to act downstream of
PINK1 [26, 51] and PINK1 is necessary for CCCP-induced
PARKIN translocation to mitochondria [28], we investigat-
ed whether the starvation-triggered PARKIN induction
depends on PINK1. For this purpose, ex vivo primary
cortical neuron cultures (DIV 14) of wt and PINK1-ko mice
bred from littermates [27] were subjected to starvation
stress. Significant inductions from 4 h on with a threefold
peak around 8 h were observed for PARKIN mRNA levels
both in wt and ko cells and for PINK1 mRNA in wt cells
(Fig. 5a, b). These findings indicate that starvation-
triggered PARKIN transcription is not controlled by PINK1
expression and are in agreement with the previous data
from neuroblastoma cells where a significant upregulation
occurred earlier for PARKIN than for PINK1 (Figs. 1 and 2).
To test whether the loss of PINK1 affects PARKIN
translocation to lysosomes, MEF from wt and PINK1-ko
Neurogenetics (2012) 13:9–21 15animals were transfected with the cherry-GFP-Parkin con-
struct. After 2 days MEF were incubated either with control
medium containing 15% bovine growth serum (DMEM+
BGS) or with starvation medium (HBSS–BGS) for 16 h.
Confocal microscopy analysis demonstrated similar formation
of red PARKIN punctae in MEF from wt and PINK1-ko mice
(Fig. S2), confirming the PINK1 independence of PARKIN
induction and lysosomal translocation during starvation.
In summary, their regulation pattern after drug exposure
and their phasicinduction duringstarvation but not during ER
or oxidative stress [38] indicate that PARKIN and PINK1 are
coregulated during trophic deprivation and undergo parallel
fates or play similar roles in response to starvation.
Discussion
In this study we investigated the involvement and the
regulation of parkinsonism-related genes in response to serum
and nutrient starvation. Our expression analyses document a
prominent role for PARKIN in growth factor signaling: during
unavailability of serum and nutrients, neural SH-SY5Y cells
induce PARKIN more than other published pathway compo-
nents [20] in a phasic pattern for mRNA levels at 8–2 4ha f t e r
starvation, in a process dependent on PI3K-Akt-mTOR
signaling and autophagy. These data are supported by
alterations of PARKIN mRNA levels after application of
pharmacological drugs targeting the PI3K-Akt-mTOR path-
way, as we found a significant upregulation of the PARKIN
transcript in unstarved cells after specific inhibition of the
PI3K-Akt-mTOR phosphorylation cascade either through
LY294002 or through rapamycin. The PI3K-Akt signaling
is involved in a number of different pathways including cell
growth, proliferation, cell cycle control, cell migration and
invasion, survival, protein, glycogen and fatty acid synthesis
[52]. While the upregulation of PARKIN mRNA in unstarved
cells after LY294002 treatment is most probably due to
LY294002’s ability to mimic starvation, it could be also/
additionally a compensatory antiapoptotic mechanism. As
Akt blocks Bax conformation changes and mitochondrial
translocation [53, 54] and PARKIN has antiapoptotic
properties [55–58], an increase of the PARKIN transcript
could therefore compensate for the LY294002-mediated
inhibition of Akt.
Our results are compatible with strong biochemical
evidence in peripheral cell types showing the ubiquitin E3
ligasePARKINabletomodulateEGFreceptortraffickingand
promote PI3K-Akt signaling through a direct interaction
between the PARKIN ubiquitin-like (Ubl) domain and the
ubiquitin-interacting motif of the protein Eps15, a component
of the RTK endocytosis machinery [14], indicating that
PARKIN function affects RTK signaling and that a dysre-
gulation could be relevant for the nervous system.
Published data about transcriptional dysregulation in PD
are scarce and usually not controlled by time course
analyses, in spite of the intense investigations into PD
pathogenesis and into the dozen novel PD genes over the
past decade [59]. A genome-wide survey of the brain
transcriptome from the MPP
+-treated mouse model of PD
identified an upregulated expression of the immediate early
gene SGK1 as the prominent effect [46]. SGK1 transcrip-
tion is strongly stimulated by serum or specific growth
factors such as insulin but also by other stressors such as
high glucose concentrations or oxidative stress and is
activated by PI3K signaling [60]. SGK1 exerts an antiapop-
totic effect through its inhibitory phosphorylation of FOXO3a
and BAD [61]. The transcription factor FOXO3a is induced
by nutrient restriction and oxidative stress, is inhibited by
Akt-signaling, and mediates the protective upregulation of
antioxidant proteins such as MnSOD and later the proapop-
totic regulation of FasL, Bim, and Bcl-6 [62]. FOXO3a was
observed to be sequestered into Lewy bodies, the pathogno-
monic protein aggregates in neurons affected by PD [44].
Thus, SGK1 and FOXO3a represent credible examples of
transcriptional dysregulation in PD, both being implicated in
stress-dependent PI3K-Akt growth signaling.
Our analysis whether PARKIN expression levels depended
on the presence of serum growth factors showed similarly
strong effects early on for FOXO3a and SGK1, later for
PARKIN and PINK1 in dopaminergic neuronal cells (Fig. 1).
This effect could be maximized to a twofold PINK1
transcript induction and sixfold PARKIN induction upon the
additional removal of nutrients from the culture medium
(Fig. 2). This transcript induction served not only to
compensate the ongoing PARKIN protein sequestration in
autophagosomes and lysosomes (Fig. 3), but was sufficient
Fig. 3 PARKIN translocates to lysosomes duringstarvation.a SH-SY5Y
cells were transfected with cherry-GFP-PARKIN and after 2 days
incubated with either control medium (RPMI+FCS) or starvation
medium (HBSS−FCS), fixed afterwards and examined by LSM. Starting
from 8 h incubation with HBSS medium, in addition to the cytoplasmic
fluorescence, PARKIN punctae appeared that exhibited only red (cherry)
but no green (GFP) fluorescence. In contrast, cells kept in RPMI+10%
FCS showed these PARKIN punctae at later time points and lower
frequency. b HeLa cells were transfected with cherry-GFP-PARKIN and
after 2 days incubated for 2 h with starvation medium (HBSS−FCS)
containing bafilomycin A1 (10 nM) or vehicle (0.1% DMSO) and fixed
afterwards. Bafilomycin A1 treatment reduced the amount of PARKIN
punctae, as indicated by their red and green staining. c–e HeLa cells were
transfected with cherry-GFP-PARKIN and after 2 days incubated for 16 h
with starvation medium (HBSS−FCS), fixed afterwards and stained for
the lysosomal marker protein LAMP-1 (c)o rL A M P - 2( d) and p62/
SQSTM1 (e). A partial colocalization as indicated by yellow staining in
the merged image as well as engulfment of red cherry-PARKIN punctae
by lysosomes is visible (insets represent single slices). Furthermore
cherry-PARKIN punctae convincingly colocalize with p62/SQSTM1. f
SH-SY5Y cells were amino acid and serum starved (HBSS−FCS)o r
nonstarved for 16 h and analyzed for the LC3-II/GAPDH ratio to monitor
autophagosome formation. LC3-I conversion to LC3-II was controlled by
adding bafilomycin A1 (5 nM, 16 h) in addition to starvation

16 Neurogenetics (2012) 13:9–21to elevate the PARKIN protein steady-state levels threefold
after 36 h in a sustained fashion, suggesting that PARKIN is
specifically needed during this period, hours after maximal
LC3-II conversion and induction of lysosomal degradation
(compare the time courses for PARKIN protein and LC3-II
in Figs. 2ba n d3a, f). A degradation of PARKIN by
lysosomes was implicated after CCCP treatment [28, 29, 63],
and our data show that inhibition of the autophago-lysosomal
pathway during starvation, e.g., by bafilomycin A1 signifi-
cantly reduced PARKIN mRNA levels, indicating a similar
fate for PARKIN during starvation. However, CCCP-induced
PARKIN degradation was dependent on PINK1, while
Neurogenetics (2012) 13:9–21 17starvation-triggered PARKIN induction became significant
before the PINK1 induction (Fig. 2), and appeared indepen-
dent from PINK1 (Fig. 5), suggesting only partially shared
upstream regulation mechanisms and implying that PARKIN
participates in different pathways in stress response depend-
ing on the specific stressor.
Thus, serum deprivation and nutrient starvation result not
only in the known early expression regulation of FOXO3a
and SGK1 during the early period of growth factor signaling
and autophagosome formation (until 12 h in our assay, see
Fig. 3f) but also in a later strong upregulation of PARKIN
and PINK1 levels, which could exert protective antiapoptotic
effects [64]. The data are compatible with the previously
reported dependence of PINK1 expression on the activity of
the phosphatase PTEN, which antagonizes the PI3K-Akt-
mTOR kinase signaling cascade [65]. Cell type-specific
regulation of PARKIN had already been noted after ER or
proteasomal stress [38, 39], but a time course correlation of
Fig. 5 Starvation-triggered
PARKIN induction and translo-
cation to lysosomes occur inde-
pendent of PINK1 expression.
Primary neuron cultures of wild-
type (wt) and PINK1-knockout
mice (ko) littermates were
starved with HBSS medium or
nonstarved for 24 h (CON). a
PINK1 and b PARKIN mRNA
levels were analyzed by qPCR,
indicating that the PARKIN in-
duction is independent of
Fig. 4 Pharmacological modu-
lation of PARKIN expression. a
SH-SY5Y cells were treated
with control (RPMI+FCS)o r
starvation medium (HBSS−
FCS) containing either 0.05%
DMSO, 5 nM bafilomycin A1
(BAF), 0.5 μM rapamycin
(RAP), 25 μM LY294002 (LY),
or nothing (CON) and incubated
for 16 h. Significance was de-
termined between unstarved
cells (white bar, CON) and
unstarved treated cells as well as
between starved cells (black bar,
CON) and starved treated cells.
Analysis of PARKIN mRNA
demonstrated clearly its modu-
lation by the applied drugs; n=
4. b SH-SY5Y cells were treated
as in a and after 24 h PARKIN
expression levels were deter-
mined by western blot, support-
ing the mRNA data presented in
a
18 Neurogenetics (2012) 13:9–21this effect to cellular processes or an investigation into the
mechanisms involved was not attempted, except an identi-
fication of ATF4 as transcription factor of PARKIN [15].
In conclusion, our systematic expression studies of dopa-
minergic neural cells documented in a time course over 72 h
after starvation and treated with drugs to modulate specific
pathwaysallconsistentlypointtoanimportantroleofPARKIN
and PINK1 in the serum- and nutrient-dependent signaling,
suggesting that they act closely together in this pathway. It
would be interesting to investigate whether additional
parkinsonism-relevantgenesareinvolvedinthesamesignaling
network; similar expression profiling studies could be useful to
screen novel disease-associated candidate genes and elucidate
their putative roles in stress response pathways.
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